Literature DB >> 9139081

Detection of adenovirus DNA in peripheral blood mononuclear cells by polymerase chain reaction assay.

P Flomenberg1, E Gutierrez, V Piaskowski, J T Casper.   

Abstract

Adenovirus can establish persistent infections which may reactivate and cause disease in immunocompromised hosts. Lymphocytes have been postulated to serve as a site of adenoviral persistence based upon the ability to isolate adenovirus from tonsils and to detect adenovirus DNA by Southern blot hybridization in peripheral blood mononuclear cells (PBMC). To test this hypothesis, a more sensitive and specific polymerase chain reaction (PCR) assay was developed to detect adenovirus DNA. Two sets of nested primers were designed to conserved sequences in the adenovirus E1A and hexon genes. The E1A and hexon primers amplified DNA from representative adenoviral serotypes in all six adenoviral groups (A-F). Both primers detected a single copy of the adenovirus type 2 genome but were less sensitive for the group B type 35. None of 33 PBMC specimens from healthy adults and only one of 40 pediatric samples was positive (at a low level) for adenovirus DNA by nested PCR assay. In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA. It is concluded that, in contrast to a previous study, PBMC are not a common site of persistent group C adenoviral infection. In addition, assay of PBMC by the adenovirus-specific PCR may help detect early invasive disease and warrants further evaluation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9139081     DOI: 10.1002/(sici)1096-9071(199703)51:3<182::aid-jmv7>3.0.co;2-2

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  10 in total

1.  Rapid typing of human adenoviruses by a general PCR combined with restriction endonuclease analysis.

Authors:  A Allard; B Albinsson; G Wadell
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

Review 2.  Epigenetics and the dynamics of chromatin during adenovirus infections.

Authors:  Kelsey L Lynch; Linda R Gooding; Charlie Garnett-Benson; David A Ornelles; Daphne C Avgousti
Journal:  FEBS Lett       Date:  2019-12-15       Impact factor: 4.124

3.  Comparison of Three Adenovirus Quantitative PCR Assays with ATCC Reference Strains and Clinical Samples.

Authors:  Kimberly Starr; Alexander L Greninger; Negar Makhsous; Keith R Jerome; Linda Cook
Journal:  J Clin Microbiol       Date:  2019-10-23       Impact factor: 5.948

Review 4.  Adenoviruses in immunocompromised hosts.

Authors:  Marcela Echavarría
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

5.  Adenovirus DNA in Guthrie cards from children who develop acute lymphoblastic leukaemia (ALL).

Authors:  E Honkaniemi; G Talekar; W Huang; G Bogdanovic; E Forestier; U von Doblen; M Engvall; D A Ornelles; L R Gooding; B Gustafsson
Journal:  Br J Cancer       Date:  2010-03-02       Impact factor: 7.640

6.  Latent species C adenoviruses in human tonsil tissues.

Authors:  C T Garnett; G Talekar; J A Mahr; W Huang; Y Zhang; D A Ornelles; L R Gooding
Journal:  J Virol       Date:  2008-12-24       Impact factor: 5.103

7.  Prevalence and quantitation of species C adenovirus DNA in human mucosal lymphocytes.

Authors:  C T Garnett; D Erdman; W Xu; Linda R Gooding
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

8.  Multiplexed, real-time PCR for quantitative detection of human adenovirus.

Authors:  Z Gu; S W Belzer; C S Gibson; M J Bankowski; R T Hayden
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

9.  Adenoviruses in lymphocytes of the human gastro-intestinal tract.

Authors:  Soumitra Roy; Roberto Calcedo; Angelica Medina-Jaszek; Martin Keough; Hui Peng; James M Wilson
Journal:  PLoS One       Date:  2011-09-30       Impact factor: 3.240

10.  Neonatal infection with species C adenoviruses confirmed in viable cord blood lymphocytes.

Authors:  David A Ornelles; Linda R Gooding; C Garnett-Benson
Journal:  PLoS One       Date:  2015-03-12       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.